IP Library Granted Patent US 9,451,884
Granted Patent B2
US 9,451,884 · App. 13/253,767 · Granted Sep 27, 2016

Device and method for in vivo detection of clots within circulatory vessels

Inventors: Vladimir Pavlovich Zharov (Little Rock, AR); Ekaterina Galanzha (Little Rock, AR)
Assignee: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
A61B5/0059A61B5/0095A61B5/412A61B5/415A61B5/416A61B5/418A61B8/06A61B8/481A61K49/22B03C1/288B03C1/30G01N21/1702G01N29/2418G01N29/4427A61B8/08A61B18/1815A61B18/20B03C2201/06B03C2201/26G01N15/147G01N15/1425G01N15/1434G01N2015/1477G01N2201/0221
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,451,884
App. No.
13/253,767
Granted
Sep 27, 2016
Kind
B2
Abstract

A device and method of using the device to detect the presence and composition of clots and other target objects in a circulatory vessel of a living subject is described. In particular, devices and methods of detecting the presence and composition of clots and other target objects in a circulatory vessel of a living subject using in vivo photoacoustic flow cytometry techniques is described.

Claims (8)

1. A device for the continuous monitoring of a circulatory vessel of a living organism, comprising:

a. an in vivo flow cytometer, wherein the in vivo flow cytometer comprises

i. a pulsed laser configured to pulse target objects comprising light absorbing red blood cells and non-absorbing clots within the circulatory vessel with a plurality of laser pulses at a pulse wavelength ranging between about 400 nm and about 2500 nm;

ii. an ultrasound transducer configured to receive photoacoustic signals emitted by the target objects in response to the laser pulses and generate an output; and

iii. an optical module configured to convert the wavelength, pulse rate, or both wavelength and pulse rate of the laser pulses emitted by the pulsed laser to desired values; and

b. a processor configured to:

receive the output from the ultrasound transducer, wherein the output comprises a photoacoustic pattern; and

analyze the output to determine the presence of any negative dips in the photoacoustic pattern which are below a threshold, wherein the threshold is established such that a negative dip below the threshold indicates the presence of a clot.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2018
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 047667/0515 →
CONFIRMATORY LICENSE Recorded Nov 18, 2011
From: UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027252/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2011
From: ZHAROV, VLADIMIR; GALANZHA, EKATERINA
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 027220/0364 →
Continuity (4)
Continuation In Part 12945576 · Nov 12, 2010
Continuation In Part 12334217 · Dec 12, 2008
Provisional Application 61013543 · Dec 13, 2007
Related Publication 20120065490A1 · Mar 15, 2012